J. Powell

发表

Fosinopril, a Phosphinic Acid Inhibitor of Angiotensin I Converting Enzyme: In Vitro and Preclinical In Vivo Pharmacology

T. Waldron, D. W. Cushman, J. M. Deforrest, 1989, Journal of cardiovascular pharmacology.

Discovery of N-isoxazolyl biphenylsulfonamides as potent dual angiotensin II and endothelin A receptor antagonists.

Natesan Murugesan, S. Chong, J. Barrish, 2002, Journal of medicinal chemistry.

Chapter 7. Antihypertensive Agents

P. Sprague, J. Powell, 1984 .

Intrauterine pressure changes during dysmenorrhea therapy.

J. Powell, R. P. Smith, 1982, American journal of obstetrics and gynecology.

Chronic dual inhibition of angiotensin-converting enzyme and neutral endopeptidase during the development of left ventricular dysfunction in dogs.

F. Spinale, G. Mcdaniel, J. Powell, 1998, Journal of cardiovascular pharmacology.

Angiotensin-converting enzyme inhibition and angiotensin II subtype-1 receptor blockade during the progression of left ventricular dysfunction: differential effects on myocyte contractile processes.

M. Webb, F. Spinale, J. Powell, 1997, The Journal of pharmacology and experimental therapeutics.

Simultaneous objective and subjective evaluation of meclofenamate sodium in the treatment of primary dysmenorrhea.

J. Powell, R. P. Smith, 1987, American journal of obstetrics and gynecology.

The effects of endothelin-A receptor blockade during the progression of pacing-induced congestive heart failure.

M. Webb, S. Moreland, F. Spinale, 1998, Journal of the American College of Cardiology.

Angiotensin II subtype-1 receptor blockade during the development of left ventricular hypertrophy in dogs: effects on ventricular and myocyte function.

F. Spinale, J. Powell, J. Walker, 1997, Journal of cardiovascular pharmacology.

Isoproterenol-induced cardiac hypertrophy: modifications in characteristics of beta-adrenergic receptor, adenylate cyclase, and ventricular contraction.

R. Priest, J. Powell, J. Kuo, 1979, Endocrinology.

LV and myocyte structure and function after early recovery from tachycardia-induced cardiomyopathy.

F. Spinale, J. Powell, R. Mukherjee, 1995, The American journal of physiology.

Chapter 7. Antihypertensive Agents

P. Sprague, J. Powell, 1984 .

Preclinical Pharmacology of Zofenopril, an Inhibitor of Angiotensin I Converting Enzyme

T. Waldron, D. W. Cushman, J. M. Deforrest, 1989, Journal of cardiovascular pharmacology.

BMS‐180560, an insurmountable inhibitor of angiotensin II‐stimulated responses: comparison with losartan and EXP3174

M. Poss, S. Moreland, K. Dickinson, 1994, British journal of pharmacology.

Vasopeptidase Inhibition In A Canine Model Of Exercise‐Induced Left Ventricular Dysfunction

J. Powell, H. Holzgrefe, S. R. Arthur, 2002, Clinical and experimental pharmacology & physiology.

Inhibition of theophylline clearance by cimetidine but not ranitidine.

J. Powell, W. Wargin, R. Cross, 1984, Archives of internal medicine.

Poor rectal absorption of trimethoprim/sulphamethoxazole in treating Pneumocystis carinii pneumonia.

R. Dorr, J. Powell, D. Barry, 1981, Postgraduate medical journal.

Substituted 1,2,3,4-tetrahydroaminonaphthols: antihypertensive agents, calcium channel blockers, and adrenergic receptor blockers with catecholamine-depleting effects.

S. Moreland, J. Powell, J. L. Bergey, 1987, Journal of medicinal chemistry.

(Phosphinyloxy)acyl amino acid inhibitors of angiotensin converting enzyme (ACE). 1. Discovery of (S)-1-[6-amino-2-[[hydroxy(4-phenylbutyl)phosphinyl]oxy]-1-oxohexyl]-L -proline a novel orally active inhibitor of ACE.

D W Cushman, D. W. Cushman, J. M. Deforrest, 1988, Journal of medicinal chemistry.

A Review of the New Angiotensin II‐Receptor Antagonist Irbesartan

D. Nisato, R. Reeves, J. Powell, 1998 .

Angiotensin-converting enzyme inhibitors. Mercaptan, carboxyalkyl dipeptide, and phosphinic acid inhibitors incorporating 4-substituted prolines.

D W Cushman, D. W. Cushman, J. M. Deforrest, 1988, Journal of medicinal chemistry.

Avian Blood Oxygen Capacity

J. Powell, J. D. Burke, 1966 .

Cimetidine and lidocaine.

J. Powell, 1983, Annals of internal medicine.

Bradykinin B2 receptor-mediated chronotropic effect of bradykinin in isolated guinea pig atria.

B. Tesfamariam, J. Powell, G. T. Allen, 1995, European journal of pharmacology.

Chiari-Frommel syndrome as a part of the Zollinger-Ellison multiple endocrine adenomatosis complex.

J. Powell, R. Le Briggs, 1969, California medicine.

Angiotensin-converting enzyme inhibition and the progression of congestive cardiomyopathy. Effects on left ventricular and myocyte structure and function.

Jennifer D. Walker, F. Spinale, J. Powell, 1995, Circulation.

Ceranapril (SQ 29,852), an Orally Active Inhibitor of Angiotensin Converting Enzyme (ACE)

T. Waldron, J. Powell, C. Harvey, 1990, Journal of cardiovascular pharmacology.

Pressor responses induced by Bay K 8644 involve both release of adrenal catecholamines and calcium channel activation

S. Moreland, S. D. Kimball, J. Powell, 1988, British journal of pharmacology.

The objective evaluation of dysmenorrhea therapy.

J. Powell, R. P. Smith, 1980, American journal of obstetrics and gynecology.

CHARACTERIZATION OF VASCULAR HISTAMINE RECEPTORS IN THE RAT

J. Powell, L. BLAIR SHAMEL, 1979, British journal of pharmacology.

Mefenamic acid for dysmenorrhea in patients with intrauterine devices.

J. Powell, R. P. Smith, 1980, JAMA.

Antihypertensive effects of a novel endothelin-A receptor antagonist in rats.

T. Waldron, S. Moreland, J. Powell, 1995, Hypertension.

Irbesartan lowers blood pressure and ameliorates renal injury in experimental non-insulin-dependent diabetes mellitus.

B. Kasiske, H. Oda, W. Keane, 1997, Kidney international. Supplement.

Blood Pressure Lowering and Renal Hemodynamic Effects of Fosinopril in Conscious Animal Models

T. Waldron, D. W. Cushman, J. M. Deforrest, 1990, Journal of cardiovascular pharmacology.

Effect of renal pressor systems on vascular capacity during hemorrhage.

J. Powell, D. Ducharme, 1974, American Journal of Physiology.

The influence of cimetidine vs ranitidine on theophylline pharmacokinetics

J. Powell, W. Wargin, J. Rogers, 1982 .

Angiotensin-converting enzyme inhibitors: accomplishments and challenges.

M. Ondetti, D. W. Cushman, J. Powell, 1987, Clinical and experimental hypertension. Part A, Theory and practice.